Pieris Pharmaceuticals Inc (PIRS)
16.98
+0.11
(+0.65%)
USD |
NASDAQ |
Oct 31, 16:00
17.20
+0.22
(+1.30%)
After-Hours: 20:00
Pieris Pharmaceuticals Cash from Operations (Quarterly): -1.48M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.48M |
| March 31, 2024 | -6.996M |
| December 31, 2023 | -19.67M |
| September 30, 2023 | -9.723M |
| June 30, 2023 | -13.43M |
| March 31, 2023 | -11.00M |
| December 31, 2022 | -12.93M |
| September 30, 2022 | -8.778M |
| June 30, 2022 | -15.58M |
| March 31, 2022 | -22.64M |
| December 31, 2021 | -10.94M |
| September 30, 2021 | -14.48M |
| June 30, 2021 | 29.91M |
| March 31, 2021 | -12.14M |
| December 31, 2020 | -13.42M |
| September 30, 2020 | -7.57M |
| June 30, 2020 | -9.778M |
| March 31, 2020 | -15.13M |
| December 31, 2019 | -13.97M |
| September 30, 2019 | -12.65M |
| June 30, 2019 | -10.73M |
| March 31, 2019 | -15.11M |
| Date | Value |
|---|---|
| December 31, 2018 | -9.058M |
| September 30, 2018 | -14.36M |
| June 30, 2018 | -8.988M |
| March 31, 2018 | 31.34M |
| December 31, 2017 | -4.694M |
| September 30, 2017 | 35.20M |
| June 30, 2017 | -6.522M |
| March 31, 2017 | 25.77M |
| December 31, 2016 | -6.729M |
| September 30, 2016 | -3.575M |
| June 30, 2016 | -6.110M |
| March 31, 2016 | 2.027M |
| December 31, 2015 | -2.492M |
| September 30, 2015 | -3.537M |
| June 30, 2015 | -3.083M |
| March 31, 2015 | -3.593M |
| September 30, 2014 | -0.0139M |
| June 30, 2014 | -0.0081M |
| March 31, 2014 | -0.0003M |
| December 31, 2013 | -0.0022M |
| September 30, 2013 | -0.0045M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.64M
Minimum
Mar 2022
29.91M
Maximum
Jun 2021
-9.987M
Average
-12.14M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 13.31M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.176M |
| Free Cash Flow | -37.87M |
| Free Cash Flow Per Share (Quarterly) | -1.139 |
| Free Cash Flow Yield | -175.8% |